Prescient Therapeutics Limited (ASX:PTX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0430
0.00 (0.00%)
Aug 25, 2025, 4:10 PM AEST

Prescient Therapeutics Revenue

In the fiscal year ending June 30, 2025, Prescient Therapeutics had annual revenue of 4.36M AUD with 17.35% growth. Prescient Therapeutics had revenue of 3.11M in the half year ending June 30, 2025, with 164.84% growth.

Revenue
4.36M
Revenue Growth
+17.35%
P/S Ratio
10.27
Revenue / Employee
1.45M
Employees
3
Market Cap
44.73M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20254.36M644.03K17.35%
Jun 30, 20243.71M1.28M52.89%
Jun 30, 20232.43M538.79K28.52%
Jun 30, 20221.89M703.86K59.37%
Jun 30, 20211.19M156.14K15.17%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Pro Medicus212.98M
Cochlear2.34B
Sonic Healthcare9.65B
Ramsay Health Care17.12B
Telix Pharmaceuticals1.01B
Ansell3.00B
Mesoblast9.16M
Revenue Rankings